Tandem Diabetes Care, Inc.

US$16.91As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TNDMHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (11.95%)
Div yield —
ROE (36.74%)
Medical Devices
Beta (5Y) 1.60
PE TTM —
TSR TTM 20.79%
Mkt cap US$1.180B
ROIC (6.01%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$17
2.76%
373.49%
Hold 12|8|3|0|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.31
0.34
0.37
0.38
24.44%
29.88%
26.61%
33.47%
Revenue$M
99.87
104.0
104.3
102.2
14.02%
13.64%
8.21%
8.38%
Peers (US$1.180B)
Cap (US$)
PE
1.104B
46.16x
1.162B
17.03x
Capital
TTM
5Y
10Y
Leveragex
0.456
0.556
0.442
EBIT/Intx
3.618
0.064
0.075
Own earn%
(229.73)
(70.80)
(83.17)
Sh yield%
29.46
58.13
57.05
Owners
Insiders/Inst%
4.42
60.28
Short interest%
2.22
SBC / revenue%
2.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
0–5
$1 testx
0.1
Incr. ROIC%
9